Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma

European Journal of Dermatology

Volumn 15, Issue 2, 2005, Pages 110-112

  Technau, Kristin ^a   Renkl, Andreas ^a   Norgauer, Johannes ^b   Ziemer, Mirjana ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Cyclosporine; Myelodysplastic syndrome; Necrolytic migratory erythema

Indexed keywords

BISOPROLOL; CLOBETASOL; CYCLOSPORIN A; DESOXIMETASONE; GLUCAGON; RAMIPRIL; STEROID;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; ERYTHEMA; GLUCAGON BLOOD LEVEL; GLUCAGONOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE VILLUS ATROPHY; JEJUNUM CANCER; LIVER NECROSIS; MALE; MYELODYSPLASTIC SYNDROME; NECROLYTIC MIGRATORY ERYTHEMA; PARANEOPLASTIC SYNDROME; RECTUM CARCINOMA; SKIN BIOPSY; SKIN MANIFESTATION; THROMBOCYTOPENIA;

AGED; AGED, 80 AND OVER; ERYTHEMA; GLUCAGONOMA; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; PANCREATIC NEOPLASMS; PARANEOPLASTIC SYNDROMES;

EID: 15944405386     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Binnick AN, Spencer SK, Dennison Jr. WL, et al. Glucagonoma syndrome. Report of two cases and literature review. Arch Dermatol 1977; 113: 749-54.
2. Thorisdottir K, Camisa C, Tomecki KJ, et al. Necrolytic migratory erythema: a report of three cases. J Am Acad Dermatol 1994; 30: 324-9.
3. Van der Loos TL, Lambrecht ER, Lambers JC. Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine. J Am Acad Dermatol 1987; 16: 468-72.
4. El Darouty M. Abu el Ela M. Necrolytic migratory erythema without glucagonoma in patients with liver disease. J Am Acad Dermatol 1996; 34: 1092-3.
5. Walker NP. Atypical necrolytic migratory erythema in association with a jejunal adenocarcinoma. J R Soc Med 1982; 75: 134-5.
6. Konstantinow A, Balda BR, Starz H. Erythema necrolyticum migrans after rectal adenocarcinoma. Hautarzt 1998; 49: 591-5.
7. Wilkinson SM, Cartwright PH, Allen C, et al. Necrolytic migratory erythema: association with neuroendocrine tumour with predominant insulin secretion. Br J Dermatol 1990; 123: 801-5.
8. Schwartz RA. Glucagonoma ond pseudoglucagonoma syndromes, Inf J Dermatol 1997; 36: 81-9.
9. Goodenberger DM, Lawley TJ, Strober W, et al. Necrolytic migratory erythema without glucagonoma. Arch Dermatol 1979; 115: 1429-32.
10. Wilkinson DS. Necrolytic migratory erythema with carcinoma of the pancreas. Irans St Johns Hosp Dermatol Soc 1973; 59: 244-50.
11. Guan M. Application of cyclosporine a in myelodysplastic syndrome. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2003; 11: 678-80.
12. Jonasova A, Neuwirtova R, Cermak J, et al. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol 1998; 100: 304-9.